
Job Title: Equity Research Associate – Cardiology, Pulmonary, Endocrine, Radiopharma
Reports to: Sr. Equity Research Analyst
Department: Equity Research
Location: New York
Salary Range: $110,000-$170,000
We are seeking a highly talented individual to add significant value to our equity research team. This individual will work directly with a Senior Managing Director to assist in preparing and executing analyses of specific areas within biotechnology, with a focus on commercial and clinical stage companies across a range of therapy areas: cardiology, pulmonary, endocrine, radiopharmaceuticals. The ideal candidate will have an innovative mindset, relentless intellectual curiosity, passion for biotech innovation and the stock market, and be a steadfast team player in a fast-paced environment. Previous relevant work experience is preferred.
Primary Duties and Responsibilities:
Experience and Qualifications:
Equal Employment Opportunity:
Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices.
Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made.

Leerink Partners is a highly specialized healthcare investment bank with a legacy of excellence in the financial industry. The firm’s experienced team delivers innovative advisory solutions, capital raising expertise, and unique insights to empower clients to achieve their strategic objectives. Since inception the firm has advised on over $70 billion, helped clients raise over $180 billion and has established itself as a trusted partner to healthcare companies and their investors. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.